Bias in the αΒ T-cell repertoire: Implications for disease pathogenesis and vaccination

Immunology and Cell Biology

Volumn 89, Issue 3, 2011, Pages 375-387

  Miles, John J ^a,b   Douek, Daniel C ^c   Price, David A ^a,c  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

T cells; T cell receptor; TCR repertoire

Indexed keywords

CYTOCHROME C; CYTOMEGALOVIRUS ANTIGEN PP65; DNA; DNA TOPOISOMERASE; GAG PROTEIN; GLUTAMATE DECARBOXYLASE 65; HLA A ANTIGEN; HLA B ANTIGEN; HLA DQA1 ANTIGEN; HLA DR ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MELAN A; MYELIN BASIC PROTEIN; MYOGLOBIN; NUCLEOPROTEIN; TETANUS TOXIN;

ALLERGY; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; APLASTIC ANEMIA; AUTOIMMUNITY; CELIAC DISEASE; CELL LINE; CHROMOSOME 14Q; CHROMOSOME 7Q; CLOSTRIDIUM TETANI; CYTOARCHITECTURE; CYTOMEGALOVIRUS; DNA RECOMBINATION; DUCHENNE MUSCULAR DYSTROPHY; EPSTEIN BARR VIRUS; EVOLUTION; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; INFLUENZA VIRUS A; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; MULTIPLE CANCER; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; NECROTIZING ARTERITIS; NONHUMAN; PARVOVIRUS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PSORIASIS VULGARIS; REACTIVE ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SIMIAN IMMUNODEFICIENCY VIRUS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ULCERATIVE COLITIS; VACCINATION;

ANIMALS; AUTOIMMUNITY; COMMUNICABLE DISEASES; HUMANS; HYPERSENSITIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; VACCINATION;

EID: 79952816254     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.139     Document Type: Review

References (153)

1. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334: 395-402.
2. Shortman K, Egerton M, Spangrude GJ, Scollay R. The generation and fate of thymocytes. Semin Immunol 1990; 2: 3-12.
3. Lieber MR. Site-specific recombination in the immune system. FASEBJ 1991; 5: 2934-2944. (Pubitemid 21905834)
4. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta Tcell receptor diversity. Science (NY) 1999; 286: 958-961.
5. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. Diversity of human alpha beta Tcell receptors. Science 2000; 288: 1135.
6. Doherty PC, Riberdy JM, Belz GT. Quantitative analysis of theCD8+T-cell responseto readily eliminated and persistent viruses. Philos Trans R Soc Lond 2000; 355: 1093-1101.
7. Moss PA, Moots RJ, Rosenberg WM, Rowland-Jones SJ, Bodmer HC, McMichael AJ et al. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA 1991; 88: 8987-8990.
8. Argaet VP, Schmidt CW, Burrows SR, Silins SL, Kurilla MG, Doolan DL et al. Dominant selection of an invariant Tcell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med 1994; 180: 2335-2340. (Pubitemid 24351615)
9. Cibotti R, Cabaniols JP, Pannetier C, Delarbre C, Vergnon I, Kanellopoulos JM et al. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J Exp Med 1994; 180: 861-872.
10. Venturi V, Price DA, Douek DC, Davenport MP. The molecular basis for public T-cell responses? Nat Rev Immunol 2008; 8: 231-238. (Pubitemid 351323289)
11. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006; 24: 419-466.
12. Schatz DG. Antigen receptor genes and the evolution of a recombinase. Semin Immunol 2004; 16: 245-256. (Pubitemid 39445623)
13. Schluter SF, Bernstein RM, Bernstein H, Marchalonis JJ. 'Big Bang' emergence of the combinatorial immune system. Dev Comp Immunol 1999; 23: 107-111. (Pubitemid 29140857)
14. Cabaniols JP, Fazilleau N, Casrouge A, Kourilsky P, Kanellopoulos JM. Mostalpha/beta T cell receptor diversity is due to terminal deoxynucleotidyl transferase. J Exp Med 2001; 194: 1385-1390. (Pubitemid 33055055)
15. Subrahmanyan L, Eberle MA, Clark AG, Kruglyak L, Nickerson DA. Sequencevariation and linkage disequilibrium in thehuman T-cell receptor beta (TCRB) locus. Am J Hum Genet 2001; 69: 381-395. (Pubitemid 32695210)
16. Mackelprang R, Livingston RJ, Eberle MA, Carlson CS, Yi Q, Akey JM et al. Sequence diversity, natural selection and linkage disequilibrium in the human Tcell receptor alpha/delta locus. Hum Genet 2006; 119: 255-266.
17. Vessey SJ, Bell JI, Jakobsen BK. Afunctionallysignificant allelic polymorphism in a T cell receptor V beta gene segment. Eur J Immunol 1996; 26: 1660-1663. (Pubitemid 26230019)
18. Gras S, Chen Z, Miles JJ, Liu YC, Bell MJ, Sullivan LC et al. Allelic polymorphism in the T cell receptor and its impact on immune responses. J Exp Med 2010; 207: 1555-1567.
19. Casrouge A, Beaudoing E, Dalle S, Pannetier C, Kanellopoulos J, Kourilsky P. Size estimate of the alpha beta TCR repertoire of naive mouse splenocytes. J Immunol 2000; 164:5782-5787. (Pubitemid 30389821)
20. Gorski J, Yassai M, Zhu X, Kissela B, Keever C, Flomenberg N et al. Circulating Tcell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 1994; 152: 5109-5119. (Pubitemid 24139107)
21. Panzara MA, Gussoni E, Steinman L, Oksenberg JR. Analysis of the Tcell repertoire using the PCR and specific oligonucleotide primers. Biotechniques 1992; 12: 728-735.
22. Miles JJ, Elhassen D, Borg NA, Silins SL, Tynan FE, Burrows JM et al. CTL recognition of a bulged viral peptide involves biased TCR selection. J Immunol 2005; 175: 3826-3834. (Pubitemid 41292043)
23. Douek DC, Betts MR, Brenchley JM, Hill BJ, Ambrozak DR, Ngai KL et al. A novel approach to the analysis of specificity, clonality and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol 2002; 168: 3099-3104. (Pubitemid 34211693)
24. Price DA, West SM, Betts MR, Ruff LE, Brenchley JM, Ambrozak DR et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 2004; 21: 793-803. (Pubitemid 39626670)
25. Miles JJ, Silins SL, Brooks AG, Davis JE, Misko I, Burrows SR. T-cell grit: large clonal expansions of virus-specific CD8+ T cells can dominate in the peripheral circulation for at least 18 years. Blood 2005; 106: 4412-4413. (Pubitemid 41775956)
26. Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, Roederer M et al. Avidity for antigen shapes clonal dominance in CD8+ Tcell populations specific for persistent DNA viruses. J Exp Med 2005; 202: 1349-1361. (Pubitemid 41668738)
27. Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA. Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res 2009; 19: 1817-1824.
28. Klarenbeek PL, Tak PP, van Schaik BD, Zwinderman AH, Jakobs ME, Zhang Z et al. Human T-cell memory consists mainly of unexpanded clones. Immunol Lett 2010; 133: 42-48.
29. Wang C, Sanders CM, Yang Q, Schroeder Jr HW, Wang E, Babrzadeh F et al. High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc Natl Acad Sci USA 2010; 107: 1518-1523.
30. Robins HS, Srivastava SK, Campregher PV, Turtle CJ, Andriesen J, Riddell SR et al. Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci Transl Med 2010; 2: 47-64.
31. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 2006; 6: 883-894. (Pubitemid 44851731)
32. Campos-Lima PO, Levitsky V, Imreh MP, Gavioli R, Masucci MG. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus. J Exp Med 1997; 186: 83-89. (Pubitemid 27304850)
33. Annels NE, Callan MF, Tan L, Rickinson AB. Changing patterns of dominant TCR usagewith maturation of an EBV-specific cytotoxic Tcell response. J Immunol 2000; 165:4831-4841.
34. Lim A, Trautmann L, Peyrat MA, Couedel C, Davodeau F, Romagné F et al. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J Immunol 2000; 165: 2001-2011. (Pubitemid 30643149)
35. Trautmann L, Labarriere N, Jotereau F, Karanikas V, Gervois N, Connerotte T et al. Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur J Immunol 2002; 32: 3181-3190. (Pubitemid 35414875)
36. Venturi V, Chin HY, Asher TE, Ladell K, Scheinberg P, Bornstein E et al. TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV. J Immunol 2008; 181: 7853-7862.
37. Tynan FE, Borg NA, Miles JJ, Beddoe T, El-Hassen D, Silins SL et al. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J Biol Chem 2005; 280: 23900-23909. (Pubitemid 40884878)
38. Miles JJ, Borg NA, Brennan RM, Tynan FE, Kjer-Nielsen L, Silins SL et al. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. J Immunol 2006; 177: 6804-6814. (Pubitemid 44715045)
39. Khan N, Cobbold M, Keenan R, Moss PA. Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency oligoclonality, and phenotype. J Infect Dis 2002; 185: 1025-1034. (Pubitemid 34297759)
40. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ et al. Cytomega-lovirus seropositivity drivestheCD8Tcell repertoiretoward greater clonality in healthy elderly individuals. J Immunol 2002; 169: 1984-1992. (Pubitemid 34857662)
41. Weekes MP, Wills MR, Mynard K, Carmichael AJ, Sissons JG. The memory cytotoxic T-lymphocyte (CTL) responseto human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J Virol 1999; 73: 2099-2108. (Pubitemid 29098114)
42. Day EK, Carmichael AJ, ten Berge IJ, Waller EC, Sissons JG, Wills MR. Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J Immunol 2007; 179:3203-3213.
43. Wynn KK, Fulton Z, Cooper L, Silins SL, Gras S, Archbold JK et al. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Blood 2008; 111:4283-4292.
44. Brennan RM, Miles JJ, Silins SL, Bell MJ, Burrows JM, Burrows SR. Predictable alphabeta T-cell receptor selection toward an HLA-B*3501- restricted human cytomegalovirus epitope. J Virol 2007; 81: 7269-7273. (Pubitemid 46986662)
45. Crompton L, Khan N, Khanna R, Nayak L, Moss PA. CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals. Blood 2008; 111: 2053-2061. (Pubitemid 351451517)
46. Garrido P, Ruiz-Cabello F, Barcena P, Sandberg Y, Cantón J, Lima M et al. Monoclonal TCR-Vbeta13.1+/CD4+/NKa+/CD8?/+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin. Blood 2007; 109: 4890-4898. (Pubitemid 46827786)
47. Bourcier KD, Lim DG, Ding YH, Smith KJ, Wucherpfennig K, Hafler DA. Conserved CDR3 regions in T-cell receptor (TCR) CD8(+) T cells that recognize the Tax11-19/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex/peptide/TCR crystal structure. J Virol 2001; 75: 9836-9843. (Pubitemid 32900119)
48. Kasprowicz V, Isa A, Jeffery K, Broliden K, Tolfvenstam T, Klenerman P et al. A highly restricted T-cell receptor dominates the CD8+ T-cell response to parvovirus B19 infection in HLA-A*2402-positive individuals. J Virol 2006; 80: 6697-6701. (Pubitemid 43927473)
49. Godthelp BC, van Tol MJ, Vossen JM, van den Elsen PJ. Longitudinal analysisof Tcells responding to tetanus toxoid in healthy subjects as well as in pediatric patients after bone marrowtransplantation: the identification of identical TCR-CDR3 regions in time suggests long-term stability of at least part of the antigen-specific TCR repertoire. Int Immunol 2001; 13: 507-518. (Pubitemid 32288546)
50. Sing GK, Li D, Chen X, Macnaughton T, Lichanska AM, Butterworth L et al. A molecular comparison of T lymphocytepopulations infiltratingthe liverand circulating in the blood of patients with chronic hepatitis B: evidence for antigen-driven selection of a public complementarity-determining region 3 (CDR3) motif. Hepatology 2001; 33: 1288-1298. (Pubitemid 32378229)
51. Umemura T, Yoshizawa K, Ota M, Katsuyama Y, Inada H, Tanaka E et al. Analysis of T cell repertoire in the liver of patients with chronic hepatitis C. Clin Exp Immunol 2000; 121: 120-126. (Pubitemid 30436024)
52. Dong L, Li P, Oenema T, McClurkan CL, Koelle DM. Public TCR use by herpes simplex virus-2-specific human CD8 CTLs. J Immunol 2010; 184: 3063-3071.
53. Gillespie GM, Stewart-Jones G, Rengasamy J, Beattie T, Bwayo JJ, Plummer FA et al. Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection. J Immunol 2006; 177: 3893-3902. (Pubitemid 44362961)
54. Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T et al. Mutuallyexclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J Virol 2007; 81: 1619-1631. (Pubitemid 46214437)
55. Simons BC, Vancompernolle SE, Smith RM, Wei J, Barnett L et al. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants. J Immunol 2008; 181: 5137-5146.
56. Deckhut AM, Allan W, McMickle A, Eichelberger M, Blackman MA, Doherty PC et al. Prominent usageof Vbeta 8.3 Tcells in the H-2Db-restricted responseto an influenza A virus nucleoprotein epitope. J Immunol 1993; 151: 2658-2666. (Pubitemid 23264517)
57. Kedzierska K, Turner SJ, Doherty PC Conserved Tcell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc Natl Acad Sci USA 2004; 101: 4942-4947. (Pubitemid 38469182)
58. Zhong W, Reinherz EL. In vivo selection of a TCR Vbeta repertoire directed against an immunodominant influenza virus CTLepitope. Int Immunol 2004; 16: 1549-1559. (Pubitemid 39480774)
59. Jones M, Ladell K, Wynn KK, Stacey MA, Quigley MF, Gostick E et al. IL-10 restricts memory T cell inflation during cytomegalovirus infection. J Immunol 2010; 185: 3583-3592.
60. Venturi V, Kedzierska K, Price DA, Doherty PC, Douek DC, Turner SJ et al. SharingofT cell receptors in antigen-specific responses is driven by convergent recombination. Proc Natl Acad Sci USA2006; 103: 18691-18696. (Pubitemid 44913472)
61. Cose SC, Kelly JM, Carbone FR. Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias. J Virol 1995; 69: 5849-5852.
62. Pewe L, Perlman S. Immune response to the immunodominant epitope of mouse hepatitis virus is polyclonal, but functionally monospecific in C57Bl/6 mice. Virology 1999; 255: 106-116. (Pubitemid 29391699)
63. Nicolo C, DiSante G, Orsini M, Rolla S, Columba-Cabezas S, Romano Spica V et al. Mycobacterium tuberculosis in the adjuvant modulates the balance of Th immune responseto self-antigen of the CNS without influencinga 'core' repertoireofspecific T cells. Int Immunol 2006; 18: 363-374. (Pubitemid 43160149)
64. Price DA, Asher TE, Wilson NA, Nason MC, Brenchley JM, Metzler IS et al. Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. J Exp Med 2009; 206: 923-936.
65. Chen ZW, Li Y, Zeng X, Kuroda MJ, Schmitz JE, Shen Y et al. The TCR repertoire of an immunodominant CD8+ T lymphocyte population. J Immunol 2001; 166: 4525-4533. (Pubitemid 32233737)
66. Hasegawa A, Moriya C, Liu H, Charini WA, Vinet HC, Subbramanian RA et al. Analysis of TCRalphabeta combinations used bysimian immunodeficiencyvirus- specific CD8+ Tcells in rhesus monkeys: implications forCTL immunodominance. J Immunol 2007; 178: 3409-3417. (Pubitemid 46417605)
67. Manuel ER, Charini WA, Sen P, Peyerl FW, Kuroda MJ, Schmitz JE et al. Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses. J Virol 2006; 80: 12032-12040. (Pubitemid 44904353)
68. Chu F, Lou Z, Chen YW, Liu Y, Gao B, Zong L et al. First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape. J Immunol 2007; 178: 944-952. (Pubitemid 46095167)
69. Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, Papagno L et al. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med 2004; 200: 1547-1557. (Pubitemid 40094179)
70. van Bockel DJ, Price DA, Munier ML, Venturi V, Asher TE, Ladell K et al. Persistent survival of prevalentclonotypes within an immunodominant HIVGag-specific CD8+ T-cell response. J Immunol 2011; 186: 359-371.
71. Venturi V, Chin HY, Price DA, Douek DC, Davenport MP. The role of production frequency in the sharing of simian immunodeficiency virus-specific CD8+ TCRs between macaques. J Immunol 2008; 181: 2597-2609.
72. La Gruta NL, Rothwell WT, Cukalac T, Swan NG, Valkenburg SA, Kedzierska K et al. Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J Clin Invest 2010; 120: 1885-1894.
73. Quigley MF, Greenaway HY, Venturi V, Lindsay R, Quinn KM, Seder RA et al. Convergent recombination shapes the clonotypic landscape of the naïve T cell repertoire. Proc Natl Acad Sci USA2010; 107: 19414-19419.
74. Cohen IR. Tending Adam's Garden: Evolving the Cognitive Immune Self. Academic Press: San Diego, CA, 1999.
75. Chattopadhyay PK, Melenhorst JJ, Ladell K, Gostick E, Scheinberg P, Barrett AJ et al. Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers. Cytometry A 2008; 73: 1001-1009.
76. Cole DK, Pumphrey NJ, Boulter JM, Sami M, Bell JI, Gostick E et al. Human TCR-binding affinity is governed by MHC class restriction. J Immunol 2007; 178: 5727-5734. (Pubitemid 46674369)
77. Dietrich PY, LeGal FA, Dutoit V, Pittet MJ, Trautman L, Zippelius A et al. Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J Immunol 2003; 170: 5103-5109. (Pubitemid 36554741)
78. Wieckowski S, Baumgaertner P, Corthesy P, Voelter V, Romero P, Speiser DE et al. Fine structural variations of alphabeta TCRs selected by vaccination with natural versus altered self-antigen in melanoma patients. J Immunol 2009; 183: 5397-5406.
79. Vignard V, Lemercier B, Lim A, Pandolfino MC, Guilloux Y, Khammari A et al. Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific Tcells. J Immunol 2005; 175: 4797-4805. (Pubitemid 41362023)
80. Serana F, Sottini A, Caimi L, Palermo B, Natali PG, Nisticò P et al. Identification of a public CDR3 motif and a biased utilization of T-cell receptorV beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients. J Transl Med 2009; 7: 21.
81. Cole DK, Edwards ES, Wynn KK, Clement M, Miles JJ, Ladell K et al. Modification of MHC anchor residuesgenerates heteroclitic peptides that alter TCR bindingand Tcell recognition. J Immunol 2010; 185: 2600-2610.
82. LeGal FA, Ayyoub M, Dutoit V, Widmer V, Jäger E, Cerottini JC et al. Distinctstructural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1. JImmunother 2005; 28: 252-257. (Pubitemid 40593991)
83. Derre L, Bruyninx M, Baumgaertner P, Ferber M, Schmid D, Leimgruber A et al. Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues. Proc Natl Acad Sci USA 2008; 105: 15010-15015.
84. Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K et al. Immunohis-tochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001; 92: 856-860. (Pubitemid 32467376)
85. Kurashige T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A et al. Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correla-tion with tumor grade. Cancer Res 2001; 61: 4671-4674. (Pubitemid 32691873)
86. Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J et al. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Cancer Res 2003; 63: 6076-6083. (Pubitemid 37187513)
87. Elkington R, Shoukry NH, Walker S, Crough T, Fazou C, Kaur A et al. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. Eur J Immunol 2004; 34: 3216-3226. (Pubitemid 39549400)
88. Wucherpfennig KW, Ota K, Endo N, Seidman JG, Rosenzweig A, Weiner HL et al. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science (NY) 1990; 248: 1016-1019.
89. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993; 362: 68-70. (Pubitemid 23087292)
90. Hong J, Zang YC, Tejada-Simon MV, Kozovska M, Li S, Singh RA et al. Acommon TCR V-D-J sequence in V beta 13.1T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol 1999; 163: 3530-3538. (Pubitemid 29431860)
91. Davies S, Nicholson T, Laura M, Giovannoni G, Altmann DM. Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis. J Neuro-pathol Exp Neurol 2005; 64: 371-377. (Pubitemid 40629126)
92. May E, Dulphy N, Frauendorf E, Duchmann R, Bowness P, Lopez de Castro JA et al. Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens 2002; 60: 299-308. (Pubitemid 36020802)
93. Saubermann LJ, Probert CS, Christ AD, Chott A, Turner JR, Stevens AC et al. Evidence of Tcell receptor beta-chain patterns in inflammatory and noninflammatory bowel disease states. Am J Physiol 1999; 276: G613-G621. (Pubitemid 29157426)
94. Probert CS, Chott A, Saubermann LJ, Stevens AC, Balk SP, Blumberg RS. Prevalence of an ulcerative colitis-associated CD8+ Tcell receptor beta-chain CDR3-region motif and its association with disease activity. J Clin Immunol 2001; 21: 126-134. (Pubitemid 32328764)
95. Yoshida K, Arai T, Kaburaki J, Ikeda Y, Kawakami Y, Kuwana M. Restricted T-cell receptor beta-chain usage by Tcells autoreactive to beta(2)-glycoprotein I in patients with antiphospholipid syndrome. Blood 2002; 99: 2499-2504. (Pubitemid 34525437)
96. Zeng W, Maciejewski JP, Chen G,Young NS. Limited heterogeneity of Tcell receptor BV usage in aplastic anemia. J Clin Invest 2001; 108: 765-773. (Pubitemid 32906206)
97. Grunewald J, Hultman T, Bucht A, Eklund A, Wigzell H. Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients. Mol Med 1995; 1: 287-296.
98. O'Keefe C L, Sobecks RM, Wlodarski M, Rodriguez A, Bell K, Kuczkowski E et al. Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem cell transplantation. Exp Hematol 2004; 32: 1010-1022. (Pubitemid 39410715)
99. Sun W, Nie H, Li N, Zang YC, Zhang D, Feng G et al. Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial Tcells of rheumatoid arthritis. Genes Iimmun 2005; 6: 248-261. (Pubitemid 40645570)
100. Prinz JC, Vollmer S, Boehncke WH, Menssen A, Laisney I, Trommler P. Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasisvulgaris. Eur J Immunol 1999; 29: 3360-3368. (Pubitemid 29484227)
101. Gussoni E, Pavlath GK, Miller RG, Panzara MA, Powell M, Blau HM et al. Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy. J Immunol 1994; 153: 4798-4805. (Pubitemid 24346875)
102. Kuwana M, Medsger Jr TA, Wright TM. Highly restricted TCR-alpha beta usage by autoreactive human Tcell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. J Immunol 1997; 158: 485-491. (Pubitemid 127483892)
103. Talken BL, Holyst MM, Lee DR, Hoffman RW. T cell receptor beta-chain third complementarity-determining region gene usage is highly restricted among Sm-B autoantigen-specific human Tcell clonesderived from patientswith connectivetissue disease. Arthritis Rheum 1999; 42: 703-709. (Pubitemid 29171990)
104. Talken BL, Bailey CW, Reardon SL, Caldwell CW, Hoffman RW. Structural analysis of TCRalpha and beta chains from human T-Cell clones specific for small nuclear ribonucleoprotein polypeptides Sm-D, Sm-B and U1-70kDa: TCR complementarity determining region 3 usage appears highly conserved. Scand J Immunol 2001; 54: 204-210. (Pubitemid 32592347)
105. Sasaki M, Nakamura S, Ohyama Y, Shinohara M, Ezaki I, Hara H et al. Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjogren's syndrome. J Immunol 2000; 164: 2823-2831. (Pubitemid 30115518)
106. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing Tcells in human lupus. J Clin Invest 1995; 95: 531-541.
107. Grunewald J, Halapi E, Wahlstrom J, Giscombe R, Nityanand S, Sanjeevi C et al. T-cell expansions with conserved T-cell receptor beta chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis. Blood 1998; 92: 3737-3744. (Pubitemid 28525201)
108. Quinn A, McInerney M, Huffman D, McInerney B, Mayo S, Haskins K et al. Tcellsto a dominant epitope of GAD65 express a public CDR3 motif. Int Immunol 2006; 18: 967-979. (Pubitemid 43983292)
109. Menezes JS, van den Elzen P, Thornes J, Huffman D, Droin NM, Maverakis E et al. A public Tcell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. J Clin Invest 2007; 117: 2176-2185. (Pubitemid 47219562)
110. Prisco A, Troncone R, Mazzarella G, Gianfrani C, Auricchio S, Even J et al. Identical T-cell receptor beta chain rearrangements are present in T cells infiltrating the jejunal mucosa of untreated celiac patients. Hum Immunol 1997; 55: 22-33. (Pubitemid 27419318)
111. Kircher MF, Haeusler T, Nickel R, Lamb JR, Renz H, Beyer K. Vbeta18.1(+) and V(alpha)2.3(+) T-cell subsets are associated with house dust mite allergy in human subjects. J Allergy Clin Immunol 2002; 109: 517-523. (Pubitemid 34234205)
112. McMurry MT, Hernandez-Munain C, Lauzurica P, Krangel MS. Enhancer control of local accessibility to V(D)J recombinase. Mol Cell Biol 1997; 17: 4553-4561. (Pubitemid 27318132)
113. Chen F, Rowen L, Hood L, Rothenberg EV. Differential transcriptional regulation of individual TCR V beta segments before gene rearrangement. J Immunol 2001; 166: 1771-1780. (Pubitemid 32114662)
114. Wilson A, Marechal C, MacDonald HR. Biased V beta usage in immature thymocytes is independent of DJ beta proximity and pT alpha pairing. J Immunol 2001; 166: 51-57. (Pubitemid 32038416)
115. Wallace ME, Bryden M, Cose SC, Coles RM, Schumacher TN, Brooks A et al. Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Immunity 2000; 12: 547-556.
116. Livak F, Burtrum DB, Rowen L, Schatz DG, Petrie HT. Genetic modulation of Tcell receptor gene segment usage during somatic recombination. J Exp Med 2000; 192: 1191-1196.
117. Quiros Roldan E, Sottini A, Bettinardi A, Albertini A, Imberti L, Primi D. Different TCRBV genes generate biased patterns of V-D-J diversity in human T cells. Immu-nogenetics 1995; 41: 91-100.
118. Melenhorst JJ, Lay MD, Price DA, Adams SD, Zeilah J, Sosa E et al. Contribution of TCR-beta locus and HLA to the shape of the mature human Vbeta repertoire. J Immunol 2008; 180: 6484-6489.
119. Sim BC, Lo D, Gascoigne NR. Preferential expression of TCR Valpha regions in CD4/CD8 subsets: class discrimination or co-receptor recognition? Immunol Today 1998; 19: 276-282. (Pubitemid 28300197)
120. Sim BC, Zerva L, Greene MI, Gascoigne NR. Control of MHC restriction byTCRValpha CDR1 and CDR2. Science (NY) 1996; 273: 963-966. (Pubitemid 26275174)
121. Candeias S, Waltzinger C, Benoist C, Mathis D. The V beta 17+ T cell repertoire: skewed J beta usage after thymic selection; dissimilar CDR3s in CD4+ versus CD8+ cells. J Exp Med 1991; 174: 989-1000.
122. Furmanski AL, Ferreira C, Bartok I, Dimakou S, Rice J, Stevenson FK et al. Public T cell receptor beta-chains are not advantaged during positive selection. J Immunol 2008; 180: 1029-1039.
123. Scott-Browne JP, White J, Kappler JW, Gapin L, Marrack P. Germline-encoded amino acids in the alphabeta T-cell receptor control thymic selection. Nature 2009; 458: 1043-1046.
124. Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY. A structural basis for immunodominant human T cell receptor recognition. Nat Immunol 2003; 4: 657-663. (Pubitemid 36874442)
125. Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, Friedman SM et al. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 1995; 181: 79-91.
126. Ishizuka J, Stewart-Jones GB, van der Merwe A, Bell JI, McMichael AJ, Jones EY. The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity 2008; 28: 171-182. (Pubitemid 351215238)
127. Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ et al. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol 2005; 6: 1114-1122. (Pubitemid 41541789)
128. Cole DK, Yuan F, Rizkallah PJ, Miles JJ, Gostick E, Price DA et al. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J Biol Chem 2009; 284: 27281-27289.
129. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med 1995; 182: 1703-1715.
130. Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, Burrows SR et al. A structural basis for the selection of dominant alphabeta Tcell receptors in antiviral immunity. Immunity 2003; 18: 53-64. (Pubitemid 36120687)
131. Borg NA, Ely LK, Beddoe T, Macdonald WA, Reid HH, Clements CS et al. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition. Nat Immunol 2005; 6: 171-180. (Pubitemid 40268198)
132. Tynan FE, Reid HH, Kjer-Nielsen L, Miles JJ, Wilce MC, Kostenko L et al. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complexclass I molecule. Nat Immunol 2007; 3: 268-276. (Pubitemid 46745376)
133. Gras S, Saulquin X, Reiser JB, Debeaupuis E, Echasserieau K, Kissenpfennig A et al. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope. J Immunol 2009; 183: 430-437.
134. Burrows SR, Rossjohn J, McCluskey J. Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol 2006; 27: 11-16. (Pubitemid 43083559)
135. Turner SJ, Kedzierska K, Komodromou H, La Gruta NL, Dunstone MA, Webb AI et al. Lackof prominent peptide-major histocompatibilitycomplexfeatures limits repertoire diversity in virus-specificCD8+Tcell populations. Nat Immunol 2005; 6: 382-389. (Pubitemid 41716778)
136. Valkenburg SA, Gras S, Guillonneau C, La Gruta NL, Thomas PG, Purcell AW et al. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold. PLoS Pathogen 2010; 6: pii: e 1001039.
137. Kedzierska K, Guillonneau C, Gras S, Hatton LA, Webby R, Purcell AW et al. Complete modification of TCR specificityand repertoireselection does not perturba CD8+ Tcell immunodominance hierarchy. Proc Natl Acad Sci USA 2008; 105: 19408-19413.
138. Day T, Graham AL, Read AF. Evolution of parasite virulence when host responses cause disease. Proc Biol Sci 2007; 274: 2685-2692. (Pubitemid 47557037)
139. McGeoch DJ, Gatherer D, Dolan A. On phylogenetic relationships among major lineages of the Gammaherpesvirinae. J Gen Virol 2005; 86: 307-316. (Pubitemid 40227941)
140. Moss DJ, Burrows SR, Silins SL, Misko I, Khanna R. The immunologyof Epstein-Barr virus infection. Philos Trans R Soc Lond Ser B 2001; 356: 475-488.
141. Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004; 4: 725-738. (Pubitemid 39574344)
142. Powers C, DeFilippis V, Malouli D, Fruh K. Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 2008; 325: 333-359.
143. Rowe M, Zuo J. Immune responsesto Epstein-Barrvirus: molecular interactions in the virus evasion of CD8+ Tcell immunity. Microbes Infect 2010; 12: 173-181.
144. Khanna R, Slade RW, Poulsen L, Moss DJ, Burrows SR, Nicholls J et al. Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. J Virol 1997; 71: 8340-8346. (Pubitemid 27446411)
145. Pawlotsky JM. Hepatitis C virus genetic variability: pathogenic and clinical implica-tions. Clin Liver Dis 2003; 7: 45-66.
146. Kennedy RC, Shearer MH, Hildebrand W. Nonhuman primate models to evaluate vaccinesafetyand immunogenicity. Vaccine 1997; 15: 903-908. (Pubitemid 27287986)
147. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 2010; 10: 11-23.
148. Gremion C, Cerny A. Hepatitis C virus and the immune system: a concise review. Rev Med Virol 2005; 15: 235-268. (Pubitemid 40992779)
149. McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory Tcells in vivo. Science 1995; 268: 106-111.
150. Fasso M, Anandasabapathy N, Crawford F, Kappler J, Fathman CG, Ridgway WM. Tcell receptor (TCR)-mediated repertoireselection and lossof TCRvbeta diversity duringthe initiation of a CD4(+) Tcell response in vivo. J Exp Med 2000; 192: 1719-1730.
151. Hochgeschwender U, Weltzien HU, Eichmann K, Wallace RB, Epplen JT. Preferential expression of a defined T-cell receptor beta-chain gene in hapten-specific cytotoxic T-cell clones. Nature 1986; 322: 376-378. (Pubitemid 16098138)
152. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998; 19: 395-404. (Pubitemid 28392279)
153. Lefranc MP. IMGT, the international Im Muno Gene Tics database. Nucleic Acids Res 2003; 31: 307-310.